The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Michael Heller1, Neehar D Parikh2, Nicholas Fidelman3, Dawn Owen4
Author information
1Department of Interventional Radiology, University of California San Francisco, 505 Parnassus Avenue, M-361, San Francisco, CA, 94143, USA. Michael.Heller@UCSF.edu.
2Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
3Department of Interventional Radiology, University of California San Francisco, 505 Parnassus Avenue, M-361, San Francisco, CA, 94143, USA.
4Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, USA.
Abstract
The incidence of hepatocellular carcinoma continues to increase worldwide. Fortunately, there have been notable recent advances in locoregional and systemic therapy. In this current review, we will highlight these new developments and future directions of hepatocellular carcinoma treatment and address the importance of a multidisciplinary approach to treatment.